L-type and T-type voltage-gated calcium channels (LTCC/TTCC)

L-type and T-type voltage-gated calcium channels (VGCCs) are critical transmembrane proteins that regulate the entry of calcium ions into cells in response to changes in membrane potential. L-type channels (Cav1 family) are high-voltage activated and are primarily responsible for excitation-contraction coupling in muscle cells and hormone secretion in endocrine cells [StatPearls: Calcium Channel Blockers, 2023]. T-type channels (Cav3 family) are low-voltage activated and play a specialized role in rhythmic firing, such as cardiac pacemaking and neuronal oscillations [PubMed: PMC4320404]. These channels are major targets for cardiovascular and neurological drugs; L-type blockers are widely used for hypertension, while T-type inhibition is relevant for treating epilepsy and chronic pain [NIH: GeneReviews, CACNA1H]. Dual L/T-type blockers, such as benidipine and efonidipine, provide therapeutic advantages in treating hypertension and renal disease by promoting balanced vasodilation of both afferent and efferent arterioles [PubMed: 15654128]. Malfunction or mutations in these channels are linked to various disorders, including cardiac arrhythmias, autism, and childhood absence epilepsy [UniProt: P29166, O43497].

Other names

Voltage-gated calcium channelsCav1 and Cav3 channelsL-type and T-type Ca2+ channelsDihydropyridine-sensitive and low-threshold calcium channels

Inhibition of calcium ion influx through the pore-forming alpha-1 subunit of voltage-gated calcium channels, leading to reduced intracellular calcium levels and decreased cellular excitability [StatPearls: Calcium Channel Blockers, 2023].